BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21741230)

  • 41. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
    Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial.
    Bonner JA; Giralt J; Harari PM; Baselga J; Spencer S; Bell D; Raben D; Liu J; Schulten J; Ang KK; Rosenthal DI
    Eur J Cancer; 2016 Sep; 64():1-11. PubMed ID: 27323346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial.
    Wu HG; Song SY; Kim YS; Oh YT; Lee CG; Keum KC; Ahn YC; Lee SW
    Cancer; 2009 Aug; 115(16):3699-708. PubMed ID: 19514089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study.
    Saarilahti K; Kajanti M; Joensuu T; Kouri M; Joensuu H
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):479-85. PubMed ID: 12243825
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.
    Bossi P; Bergamini C; Miceli R; Cova A; Orlandi E; Resteghini C; Locati L; Alfieri S; Imbimbo M; Granata R; Mariani L; Iacovelli NA; Huber V; Cavallo A; Licitra L; Rivoltini L
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):959-966. PubMed ID: 27745982
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review.
    Trotti A; Bellm LA; Epstein JB; Frame D; Fuchs HJ; Gwede CK; Komaroff E; Nalysnyk L; Zilberberg MD
    Radiother Oncol; 2003 Mar; 66(3):253-62. PubMed ID: 12742264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A pilot study evaluating the safety and microbiologic efficacy of an economically viable antimicrobial lozenge in patients with head and neck cancer receiving radiation therapy.
    El-Sayed S; Epstein J; Minish E; Burns P; Hay J; Laukkanen E
    Head Neck; 2002 Jan; 24(1):6-15. PubMed ID: 11774397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of honey on oral mucositis in patients with head and neck cancer: A meta-analysis.
    Cho HK; Jeong YM; Lee HS; Lee YJ; Hwang SH
    Laryngoscope; 2015 Sep; 125(9):2085-92. PubMed ID: 25778825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of benzydamine oral rinse in prevention and management of radiation-induced oral mucositis: A double-blind placebo-controlled randomized clinical trial.
    Sheibani KM; Mafi AR; Moghaddam S; Taslimi F; Amiran A; Ameri A
    Asia Pac J Clin Oncol; 2015 Mar; 11(1):22-7. PubMed ID: 25471468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms.
    Su CK; Mehta V; Ravikumar L; Shah R; Pinto H; Halpern J; Koong A; Goffinet D; Le QT
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):171-7. PubMed ID: 15337553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Filgrastim (r-metHuG-CSF) and its potential use in the reduction of radiation-induced oropharyngeal mucositis: an interim look at a randomized, double-blind, placebo-controlled trial.
    Schneider SB; Nishimura RD; Zimmerman RP; Tran L; Shiplacoff J; Tormey M; Contreras R; Juillard GF
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):175-80. PubMed ID: 10641576
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.
    Vadhan-Raj S; Trent J; Patel S; Zhou X; Johnson MM; Araujo D; Ludwig JA; O'Roark S; Gillenwater AM; Bueso-Ramos C; El-Naggar AK; Benjamin RS
    Ann Intern Med; 2010 Sep; 153(6):358-67. PubMed ID: 20855800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy.
    Chi KH; Chen CH; Chan WK; Chow KC; Chen SY; Yen SH; Chao JY; Chang CY; Chen KY
    J Clin Oncol; 1995 Oct; 13(10):2620-8. PubMed ID: 7595716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of elemental diet on prevention for chemoradiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma.
    Harada K; Ferdous T; Horinaga D; Uchida K; Mano T; Mishima K; Park S; Hanazawa H; Takahashi S; Okita A; Fukunaga M; Maruta J; Kami N; Shibuya K; Ueyama Y
    Support Care Cancer; 2016 Feb; 24(2):953-959. PubMed ID: 26248650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation.
    Antunes HS; Schluckebier LF; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Rampini MP; Ferreira EM; Dias FL; Teich V; Teich N; Ferreira CG
    Oral Oncol; 2016 Jan; 52():85-90. PubMed ID: 26559740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Management of oral mucositis in patients with head and neck cancer receiving chemoradiotherapy and/or molecular targeted therapy].
    Zhang XX; Ma L; Wang JL; Wu WM; Feng LC; Huang DL
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jun; 46(6):505-8. PubMed ID: 21924104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of a daily dose of Lactobacillus brevis CD2 lozenges in high caries risk schoolchildren.
    Campus G; Cocco F; Carta G; Cagetti MG; Simark-Mattson C; Strohmenger L; Lingström P
    Clin Oral Investig; 2014; 18(2):555-61. PubMed ID: 23644602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention and Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis.
    Daugėlaitė G; Užkuraitytė K; Jagelavičienė E; Filipauskas A
    Medicina (Kaunas); 2019 Jan; 55(2):. PubMed ID: 30678228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
    Bentzen SM; Saunders MI; Dische S; Bond SJ
    Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multi-Sensor Approach for the Monitoring of Halitosis Treatment via Lactobacillus brevis (CD2)-Containing Lozenges--A Randomized, Double-Blind Placebo-Controlled Clinical Trial.
    Marchetti E; Tecco S; Santonico M; Vernile C; Ciciarelli D; Tarantino E; Marzo G; Pennazza G
    Sensors (Basel); 2015 Aug; 15(8):19583-96. PubMed ID: 26266414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.